Effect of Nesting During Intramuscular Injection on Pain, Stress, and Breastfeeding Success in Cesarean-Born Term Newborns (NESTING)
The Effect of Nesting Practice on Pain, Stress Level, and Breastfeeding Success During Intramuscular Injection in Term Newborns Delivered by Cesarean Section
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Painful procedures performed during the first hours after birth, particularly intramuscular vitamin K and hepatitis B injections, are associated with significant pain and stress responses in newborns. Although several non-pharmacological interventions have been recommended to minimize procedural pain, evidence regarding the effectiveness of nesting in healthy term newborns delivered by cesarean section remains limited.
This study is designed as a prospective, single-center, parallel-group, randomized controlled trial. The study will be conducted in the newborn observation room of the Delivery Unit at Kocaeli Darıca Farabi Training and Research Hospital. Healthy term newborns (37-42 weeks of gestation) delivered by cesarean section will be enrolled after written informed parental consent is obtained. A total of 112 newborns will be randomly allocated in a 1:1 ratio to either the nesting intervention group or the routine care control group using Random Allocation Software.
Newborns assigned to the intervention group will be placed in a sterile cotton nesting position until the first intramuscular injection. Routine intramuscular administration of vitamin K and hepatitis B vaccine will be performed according to standard neonatal care. The control group will receive routine neonatal care without nesting. No additional invasive procedures will be performed for research purposes.
Pain, stress level, heart rate, respiratory rate, oxygen saturation, and settling time will be assessed before, during, and one minute after the injection. Breastfeeding success will be evaluated at the first breastfeeding after mother-infant reunion, at one hour after breastfeeding, and before hospital discharge using validated assessment tools. Outcome assessment will be performed by an independent assessor who is blinded to group allocation.
The primary objective of this study is to determine whether nesting reduces procedural pain and stress while improving physiological stability and breastfeeding success in term newborns delivered by cesarean section. The results are expected to contribute to evidence-based neonatal care by supporting the implementation of developmental, non-pharmacological interventions during routine newborn procedures.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Emine Nur Çalımlı Celep, Msc
- Número de telefone: +90 506 126 48 03
- E-mail: enurcalimli@gmail.com
Estude backup de contato
- Nome: Yasemin Dinçel, MSc
- Número de telefone: +90 545 939 49 26
- E-mail: yasemindincel96@gmail.com
Locais de estudo
-
-
Kocaeli
-
Darıca, Kocaeli, Turquia (Türkiye)
- Recrutamento
- Kocaeli Darıca Farabi Training and Research Hospital
-
Contato:
- Emine Nur Çalımlı Celep, Msc
- Número de telefone: +90 506 126 48 03
- E-mail: enurcalimli@gmail.com
-
Investigador principal:
- Sevil İnal, Prof. Dr.
-
Subinvestigador:
- Emine Nur Çalımlı Celep, Msc
-
Subinvestigador:
- Yasemin Dinçel, Msc
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Written informed consent was obtained from the parent(s) or legal guardian(s) of the newborn.
- Born by cesarean section.
- Term newborn (gestational age between 37+0 and 41+6 weeks).
- Birth weight between 2,500 g and 4,000 g.
- Clinically stable vital signs (including heart rate, respiratory rate, and oxygen saturation).
- No acute or chronic medical conditions.
- No congenital anomalies.
- No requirement for endotracheal intubation, resuscitation, or admission to the neonatal intensive care unit (NICU).
- Scheduled to receive the first intramuscular injection after birth.
Exclusion Criteria:
- Multiple birth (e.g., twins or higher-order multiples).
- Administration of vitamin K or hepatitis B vaccine before completion of the study procedures.
- Withdrawal of parental consent at any time during the study.
- Use of a pacifier, oral sucrose, or any pharmacological or non-pharmacological pain-relief intervention before completion of the outcome assessments.
- Discharge from the hospital or transfer to another healthcare facility before completion of the study procedures.
- Delayed mother-newborn reunion due to maternal general anesthesia or prolonged sedation following spinal or epidural anesthesia.
- Delayed transfer of the newborn to the mother because of prolonged surgery, intraoperative complications, or delayed postoperative stabilization.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Nesting Group
Term newborns delivered by cesarean section will receive the nesting intervention before and during routine intramuscular injection.
Pain, stress level, and breastfeeding success will be assessed using validated outcome measures.
|
Nesting is a non-pharmacological positioning intervention in which the newborn is placed in a flexed, midline posture using rolled towels or positioning supports to provide containment before and during intramuscular injection.
The intervention aims to reduce procedural pain and stress and improve breastfeeding success.
|
|
Sem intervenção: Standard Care Group
Term newborns delivered by cesarean section will receive routine care during intramuscular injection without the nesting intervention.
Pain, stress level, and breastfeeding success will be assessed using the same outcome measures.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Neonatal Pain
Prazo: Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Pain will be assessed using the Neonatal Pain, Agitation and Sedation Scale (N-PASS).
The pain/agitation component consists of five behavioral and physiological indicators, each scored from 0 to 2, yielding a total score ranging from 0 to 10. Higher scores indicate greater pain.
|
Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
|
Neonatal Stress Level
Prazo: Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Neonatal stress will be assessed using the Neonatal Stress Scale.
The scale consists of eight behavioral and physiological indicators, each scored from 0 to 2, yielding a total score ranging from 0 to 16.
Higher scores indicate greater neonatal stress.
|
Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Heart Rate
Prazo: Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Heart rate will be measured in beats per minute (bpm) to evaluate the newborn's physiological response to intramuscular injection.
Higher heart rate values indicate a greater physiological response to procedural stress.
|
Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
|
Respiratory Rate
Prazo: Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Respiratory rate will be measured in breaths per minute (breaths/min) to evaluate the newborn's physiological response to intramuscular injection.
Higher respiratory rate values indicate a greater physiological response to procedural stress.
|
Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
|
Peripheral Oxygen Saturation
Prazo: Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
Peripheral oxygen saturation (SpO₂) will be measured using pulse oximetry and reported as a percentage (%) to evaluate the newborn's physiological response to intramuscular injection.
Higher SpO₂ values indicate better oxygenation.
|
Immediately before intramuscular injection, during intramuscular injection, and 1 minute after intramuscular injection.
|
|
Breastfeeding Success
Prazo: At the first breastfeeding following mother-newborn reunion, 1 hour after the first breastfeeding, and 48 hours after birth (prior to hospital discharge).
|
Breastfeeding success will be assessed using the Bristol Breastfeeding Assessment Tool (BBAT).
The BBAT consists of four items (positioning, attachment, sucking, and swallowing), each scored from 0 to 2. Total scores range from 0 to 8, with higher scores indicating better breastfeeding effectiveness.
|
At the first breastfeeding following mother-newborn reunion, 1 hour after the first breastfeeding, and 48 hours after birth (prior to hospital discharge).
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Sevil İnal, Prof. Dr., Istanbul University-Cerrahpasa, Department of Midwifery
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- NESTING-2025-09
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .